The effects of LY2405319, an FGF21 Analog, in obese human subjects with type 2 diabetes

Gregory Gaich, Jenny Y. Chien, Haoda Fu, Leonard C. Glass, Mark A. Deeg, William L. Holland, Alexei Kharitonenkov, Thomas Bumol, Holger K. Schilske, David E. Moller

Research output: Contribution to journalArticle

475 Scopus citations

Fingerprint Dive into the research topics of 'The effects of LY2405319, an FGF21 Analog, in obese human subjects with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences